Evidence map›Paper›PMID 32407153›Full record

ArticleJournal of immunotoxicology2020

Drake W Phelps, Ashley A Fletcher, Ivan Rodriguez-Nunez, Michele R Balik-Meisner, Debra A Tokarz, David M Reif, Dori R Germolec, Jeffrey A Yoder

Open access · goldAbstract read
In one paragraph

Article in Journal of immunotoxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Ellagic Acid Mitigates Lead (Pb)-Induced Toxicity inAntioxidants (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Drake W PhelpsDepartment of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA.ORCID 0000-0001-8350-5626
Ashley A FletcherDepartment of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA.ORCID 0000-0003-2626-4867
Ivan Rodriguez-NunezDepartment of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA.ORCID 0000-0002-9947-8981
Michele R Balik-MeisnerDepartment of Biological Sciences, North Carolina State University, Raleigh, NC, USA.
Debra A TokarzDepartment of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA.ORCID 0000-0002-1802-7346
David M ReifDepartment of Biological Sciences, North Carolina State University, Raleigh, NC, USA.ORCID 0000-0001-7815-6767
Dori R GermolecNational Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
Jeffrey A YoderDepartment of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA.ORCID 0000-0002-6083-1311
North Carolina State University · USNational Institute of Environmental Health Sciences · US

Funding

Translational Research Support CoreP30ES025128 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Sue Fenton · 2015 to 2026
$18.3M
Comparative Medicine and Translational Research Training ProgramT32OD011130 · OD · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Lauren Virginia Schnabel · 2012 to 2026
$7.8M
Molecular Biotechnology Training at North Carolina State UniversityT32GM008776 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI KELLY, ROBERT M · 2000 to 2019
$3.9M
NIEHS NIH HHS P30 ES025128NIGMS NIH HHS T32 GM008776NIH HHS T32 OD011130
6 · The paper itself

Abstract

Currently, assessment of the potential immunotoxicity of a given agent involves a tiered approach for hazard identification and mechanistic studies, including observational studies, evaluation of immune function, and measurement of susceptibility to infectious and neoplastic diseases. These studies generally use costly low-throughput mammalian models. Zebrafish, however, offer an excellent alternative due to their rapid development, ease of maintenance, and homology to mammalian immune system function and development. Larval zebrafish also are a convenient model to study the innate immune system with no interference from the adaptive immune system. In this study, a respiratory burst assay (RBA) was utilized to measure reactive oxygen species (ROS) production after developmental xenobiotic exposure. Embryos were exposed to non-teratogenic doses of chemicals and at 96 h post-fertilization, the ability to produce ROS was measured. Using the RBA, 12 compounds with varying immune-suppressive properties were screened. Seven compounds neither suppressed nor enhanced the respiratory burst; five reproducibly suppressed global ROS production, but with varying potencies: benzo[a]pyrene, 17β-estradiol, lead acetate, methoxychlor, and phenanthrene. These five compounds have all previously been reported as immunosuppressive in mammalian innate immunity assays. To evaluate whether the suppression of ROS by these compounds was a result of decreased immune cell numbers, flow cytometry with transgenic zebrafish larvae was used to count the numbers of neutrophils and macrophages after chemical exposure. With this assay, benzo[a]pyrene was found to be the only chemical that induced a change in the number of immune cells by increasing macrophage but not neutrophil numbers. Taken together, this work demonstrates the utility of zebrafish larvae as a vertebrate model for identifying compounds that impact innate immune function at non-teratogenic levels and validates measuring ROS production and phagocyte numbers as metrics for monitoring how xenobiotic exposure alters the innate immune system.

Indexed as

AnimalsAnimals, Genetically ModifiedBenzo(a)pyreneBlood Cell CountCytotoxicity Tests, ImmunologicEmbryo, NonmammalianEstradiolFeasibility StudiesHigh-Throughput Screening AssaysImmunity, InnateMacrophagesMethoxychlorNeutrophilsOrganometallic CompoundsPhenanthrenesReactive Oxygen SpeciesBenzo(a)pyreneEstradiollead acetateMethoxychlorOrganometallic CompoundsphenanthrenePhenanthrenesReactive Oxygen SpeciesChemical screenendocrine disrupting compounds (EDC)high throughputleadphagocytepolycyclic aromatic hydrocarbons (PAH)reactive oxygen species (ROS)

Identifiers

PMID32407153
PMCPMC7405951
OpenAlexW3025121991

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.